跳至主要内容
临床试验/NCT01386775
NCT01386775已完成不适用

Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation

Edimer Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64
试验地点
1
主要终点
Use skin assessment techniques to characterize skin properties in male subjects affected by HED compared with healthy controls, including determination of the number of sweat ducts and the rate of sweating

研究概览

简要总结

This study in affected Hypohidrotic Ectodermal Dysplasia (HED) males and unaffected male controls, age 1 year and up, will use minimally invasive devices to image sweat ducts in intact skin, to measure stimulated sweat rate, and in a subset of subjects to collect clipped scalp hair samples for RNA analysis. This study is descriptive in nature and is intended to assess the ability to use innovative approaches to generate data from subjects over a wide age spectrum, with particular emphasis on phenotype variability between male siblings (same mutation).

详细描述

This pilot study in affected HED males and unaffected male controls, age 1 year and up, will use minimally invasive devices to image sweat ducts in intact skin, to measure stimulated sweat rate, and in a subset of subjects to collect clipped scalp hair samples for RNA analysis. This study is descriptive in nature and is intended to assess the ability to use innovative approaches to generate data from subjects over a wide age spectrum, with particular emphasis on phenotype variability between male siblings (same mutation). To this end, priority will be given to families that contain multiple affected siblings (i.e. two brothers). Summary data will be generated for the various groups tested, but no power calculations are involved.

研究设计

研究类型
Observational

入排标准

年龄范围
1 Year 至 —(Child, Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Registered and attending the 2011 NFED Family Conference;
  • One year of age or greater;
  • Conform to one of the following requirements for providing informed consent/assent:
  • if more than 18 years of age, subjects must provide signed informed consent;
  • if less than 18 years of age and it is determined that the subject is capable of providing assent, both the assent of the subject and consent of the parent(s) or guardian of that subject must be granted. Under this condition, both parents of the subject should give their permission, unless 1 parent is deceased, unknown, incompetent, or not available;
  • if the subject is incapable of providing assent, the consent of the parent(s) or guardian of the subject must be granted. Under this condition, both parents should give their consent, unless 1 parent is deceased, unknown, incompetent, or not available.
  • As described in Section 3.2 above, subjects must meet one of the following criteria:
  • Male subjects with the clinical characteristics of HED, including at least a history of decreased sweating and either abnormal teeth (fewer permanent teeth, teeth are smaller than average and often have conical crowns), and/or sparseness of scalp and body hair (Male HED subjects with an affected sibling also enrolling in the study will be given priority to be in the study);
  • Healthy male controls, i.e. either unaffected male family members or unaffected male volunteers.

排除标准

  • Known hypersensitivity to pilocarpine or pilocarpine-like muscarinic agonists;
  • Known hypersensitivity to lidocaine or lidocaine like agents;
  • Presence of pacemakers;
  • Subjects who are not able or are not willing to comply with the procedures of this protocol;
  • Subjects with any major medical problem that will prevent them from participating in this study.

结局指标

主要结局

Use skin assessment techniques to characterize skin properties in male subjects affected by HED compared with healthy controls, including determination of the number of sweat ducts and the rate of sweating

时间窗: Day of study conduct

Day 1

次要结局

  • Collecting demographic and clinical status information in male subjects affected by HED using a medical questionnaire(Day of study conduct)
  • Assessment of intrafamilial phenotypic variability in families with multiple HED-affected male siblings(Day of study conduct)
  • Evaluation of hair RNA profiles in samples from HED and unaffected male controls(Day of study conduct)
  • Confirming the presence of ectodysplasin A (EDA) gene mutations in HED subjects enrolled in this study(Day of study conduct)

研究者

发起方
Edimer Pharmaceuticals
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验